BERBERIAN LANCE 4
4 · Privia Health Group, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Privia Health (PRVA) Director Lance Berberian Receives RSUs
What Happened
- Lance Berberian, a director of Privia Health Group, Inc. (PRVA), was granted 8,463 restricted stock units (RSUs) on May 20, 2026. The award was reported as an A (award/grant) transaction at $0.00 per share (no cash paid at grant).
Key Details
- Transaction date and price: May 20, 2026 — 8,463 RSUs @ $0.00.
- Total immediate cash value reported: $0 (award of RSUs, not a purchase).
- Shares owned after transaction: Not stated in the provided filing.
- Footnote: The RSUs vest on the earlier of (i) the day immediately preceding the Company’s 2027 annual meeting of stockholders or (ii) the first anniversary of the grant (May 20, 2027 if earlier).
- Filing timeliness: Form 4 filed May 22, 2026; appears to be timely (filed within required reporting window).
Context
- RSUs are compensation awards that convert into common shares only upon vesting; they do not represent immediately tradable stock. Director grants like this are common as part of board compensation and do not by themselves indicate a buy or sell signal.
Insider Transaction Report
Form 4
BERBERIAN LANCE
Director
Transactions
- Award
Common Stock, $0.01 par value per share
[F1]2026-05-20+8,463→ 16,131 total
Footnotes (1)
- [F1]On May 20, 2026, the reporting person received 8,463 restricted stock units under the Issuer's 2021 Omnibus Incentive Plan. The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2027 annual meeting of stockholders and (ii) the first anniversary of the date of the grant.
Signature
/s/ Anita Beth Adams, as attorney-in-fact|2026-05-22